These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 26897385

  • 1. Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site.
    Lee WJ, Moon IJ, Lee SH, Won CH, Chang SE, Choi JH, Moon KC, Park CS, Huh J, Lee MW.
    J Am Acad Dermatol; 2016 Jun; 74(6):1135-43. PubMed ID: 26897385
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Applicability and prognostic value of the new TNM classification system in 135 patients with primary cutaneous anaplastic large cell lymphoma.
    Benner MF, Willemze R.
    Arch Dermatol; 2009 Dec; 145(12):1399-404. PubMed ID: 20026848
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Primary Cutaneous Anaplastic Large Cell Lymphoma With Positive ALK Expression and a Rapidly Progressive Cutaneous Nodule.
    Xue D, Li X, Ren Y, Liu Q, Yen Y, Xue L.
    Int J Surg Pathol; 2015 Jun; 23(4):333-5. PubMed ID: 25633507
    [Abstract] [Full Text] [Related]

  • 6. Cutaneous extranodal natural killer/T-cell lymphoma: a comparative clinicohistopathologic and survival outcome analysis of 45 cases according to the primary tumor site.
    Lee WJ, Jung JM, Won CH, Chang SE, Choi JH, Chan Moon K, Park CS, Huh J, Lee MW.
    J Am Acad Dermatol; 2014 Jun; 70(6):1002-9. PubMed ID: 24629518
    [Abstract] [Full Text] [Related]

  • 7. ALK-Negative Primary Cutaneous Anaplastic Large Cell Lymphoma With Systemic Involvement or Systemic ALCL With Cutaneous Lesion. A Diagnostic Dilemma.
    Gupta I, Ramteke P, Narwal A, Sharma MC, Bakhshi S, Mallick S.
    Am J Dermatopathol; 2022 May 01; 44(5):376-379. PubMed ID: 35234192
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Primary cutaneous and systemic anaplastic large cell lymphoma: clinicopathologic aspects and therapeutic options.
    Querfeld C, Khan I, Mahon B, Nelson BP, Rosen ST, Evens AM.
    Oncology (Williston Park); 2010 Jun 01; 24(7):574-87. PubMed ID: 20669794
    [Abstract] [Full Text] [Related]

  • 10. ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
    Geller S, Canavan TN, Pulitzer M, Moskowitz AJ, Myskowski PL.
    Int J Dermatol; 2018 May 01; 57(5):515-520. PubMed ID: 29057463
    [Abstract] [Full Text] [Related]

  • 11. Fatal ALK-negative systemic anaplastic large cell lymphoma presenting with disseminated cutaneous dome-shaped papules and nodules.
    Bird JE, Leitenberger JJ, Solomon A, Blauvelt A, Hopkins S.
    Dermatol Online J; 2012 May 15; 18(5):5. PubMed ID: 22630575
    [Abstract] [Full Text] [Related]

  • 12. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature.
    Magro CM, Momtahen S, Kiuru M.
    Am J Dermatopathol; 2017 Dec 15; 39(12):877-889. PubMed ID: 28570392
    [Abstract] [Full Text] [Related]

  • 13. Intralymphatic cutaneous anaplastic large cell lymphoma/lymphomatoid papulosis: expanding the spectrum of CD30-positive lymphoproliferative disorders.
    Samols MA, Su A, Ra S, Cappel MA, Louissant A, Knudson RA, Ketterling RP, Said J, Binder S, Harris NL, Feldman AL, Kim J, Kim YH, Gratzinger D.
    Am J Surg Pathol; 2014 Sep 15; 38(9):1203-11. PubMed ID: 24805854
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Anaplastic large cell lymphomas: ALK positive, ALK negative, and primary cutaneous.
    Xing X, Feldman AL.
    Adv Anat Pathol; 2015 Jan 15; 22(1):29-49. PubMed ID: 25461779
    [Abstract] [Full Text] [Related]

  • 16. Secondary cutaneous lymphoma: comparative clinical features and survival outcome analysis of 106 cases according to lymphoma cell lineage.
    Lee WJ, Won KH, Won CH, Chang SE, Choi JH, Moon KC, Park CS, Huh J, Suh C, Lee MW.
    Br J Dermatol; 2015 Jul 15; 173(1):134-45. PubMed ID: 25556641
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recurrent ALK-negative anaplastic large T-cell lymphoma presenting as necrotizing vasculitis.
    Nambudiri VE, Aboutalebi A, Granter SR, Saavedra A.
    Am J Dermatopathol; 2013 Jun 15; 35(4):512-6. PubMed ID: 23291583
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.